Anthony S Wierzbicki Selected Research

Refsum Disease (Refsum's Disease)

1/2017	The Challenges of a Successful Pregnancy in a Patient with Adult Refsum's Disease due to Phytanoyl-CoA Hydroxylase Deficiency.
11/2010	Adult Refsum disease: a form of tapetoretinal dystrophy accessible to therapy.
9/2010	The effectiveness of long-term dietary therapy in the treatment of adult Refsum disease.
8/2003	Metabolism of phytanic acid and 3-methyl-adipic acid excretion in patients with adult Refsum disease.
2/2003	Identification of PEX7 as the second gene involved in Refsum disease.
5/2002	Utilization of sterol carrier protein-2 by phytanoyl-CoA 2-hydroxylase in the peroxisomal alpha oxidation of phytanic acid.
3/2002	Refsum's disease: a peroxisomal disorder affecting phytanic acid alpha-oxidation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anthony S Wierzbicki Research Topics

Disease

32	Cardiovascular Diseases (Cardiovascular Disease) 12/2022 - 07/2003
19	Coronary Disease (Coronary Heart Disease) 07/2015 - 01/2002
15	Atherosclerosis 01/2020 - 07/2002
9	Inflammation (Inflammations) 01/2022 - 07/2003
9	Insulin Resistance 01/2022 - 05/2002
9	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2017 - 08/2008
7	Refsum Disease (Refsum's Disease) 01/2017 - 03/2002
7	Stroke (Strokes) 12/2015 - 05/2002
6	Hypertension (High Blood Pressure) 01/2021 - 07/2002
5	Pancreatitis 01/2020 - 07/2009
4	Rare Diseases (Rare Disease) 12/2022 - 01/2013
4	Muscular Diseases (Myopathy) 12/2019 - 11/2009
4	Type 2 Diabetes Mellitus (MODY) 02/2019 - 12/2006
4	Heart Diseases (Heart Disease) 07/2017 - 11/2005
4	HIV Infections (HIV Infection) 07/2014 - 11/2005
4	Hypertriglyceridemia 04/2012 - 01/2002
3	Rhabdomyolysis 11/2017 - 09/2003
3	Neoplasms (Cancer) 07/2017 - 03/2002
3	Lipodystrophy 01/2016 - 11/2005
3	Erectile Dysfunction 07/2014 - 04/2006
3	Non-alcoholic Fatty Liver Disease 07/2014 - 08/2012
3	Dyslipidemias (Dyslipidemia) 08/2013 - 01/2006
3	Atherosclerotic Plaque (Atheroma) 02/2013 - 07/2003
3	Weight Loss (Weight Reduction) 08/2012 - 01/2010
3	Vascular Diseases (Vascular Disease) 07/2012 - 07/2008
3	Hypercholesterolemia 11/2010 - 07/2004
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2010 - 05/2002
2	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 01/2020 - 01/2017
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 07/2013
2	Acute Coronary Syndrome 01/2018 - 10/2009
2	Body Weight (Weight, Body) 01/2017 - 07/2003
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 03/2014 - 08/2013
2	Homozygous Familial Hypercholesterolemia 09/2013 - 01/2011
2	Chronic Renal Insufficiency 08/2013 - 07/2013
2	Obesity 07/2013 - 09/2007
2	Carotid Artery Diseases 07/2013 - 07/2012
2	Xanthomatosis (Xanthoma) 02/2013 - 03/2006
2	Carotid Stenosis (Carotid Artery Stenosis) 07/2012 - 03/2007
2	Ataxia (Dyssynergia) 11/2010 - 03/2002
2	Thrombosis (Thrombus) 07/2008 - 07/2003
2	Osteoporosis 01/2004 - 03/2002
2	Deafness (Deaf Mutism) 09/2003 - 03/2002
2	Peroxisomal Disorders (Peroxisomal Disorder) 02/2003 - 03/2002
1	Gaucher Disease (Gaucher's Disease) 09/2021
1	Fabry Disease (Fabry's Disease) 02/2021

Drug/Important Bio-Agent (IBA)

34	LipidsIBA 01/2021 - 03/2002
24	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 07/2002
13	oxidized low density lipoproteinIBA 01/2020 - 07/2003
12	CholesterolIBA 07/2017 - 01/2004
11	LDL CholesterolIBA 01/2020 - 01/2006
9	Triglycerides (Triacylglycerol)IBA 12/2022 - 05/2002
9	HDL CholesterolIBA 12/2022 - 01/2002
9	Phytanic AcidIBA 01/2017 - 03/2002
7	Fibric Acids (Fibrates)IBA 01/2020 - 12/2006
6	Glucose (Dextrose)FDA LinkGeneric 02/2019 - 01/2004
6	LDL Lipoproteins (beta Lipoproteins)IBA 12/2017 - 07/2003
6	Niacin (Nicotinic Acid)FDA LinkGeneric 12/2014 - 02/2005
5	HDL LipoproteinsIBA 01/2020 - 11/2004
5	Pharmaceutical PreparationsIBA 09/2018 - 07/2003
5	Proteins (Proteins, Gene)FDA Link 09/2013 - 03/2002
4	ISIS 304801IBA 12/2022 - 01/2016
4	Antisense OligonucleotidesIBA 01/2020 - 04/2012
4	Lipoprotein(a)IBA 11/2017 - 01/2004
4	CreatinineIBA 09/2011 - 07/2003
3	Lipoproteins (Lipoprotein)IBA 12/2022 - 03/2002
3	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 05/2002
3	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2020 - 01/2004
3	evolocumabIBA 01/2018 - 11/2016
3	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2017 - 04/2012
3	Ezetimibe (Zetia)FDA Link 08/2013 - 07/2010
3	Simvastatin (Zocor)FDA LinkGeneric 07/2011 - 11/2009
3	Apolipoproteins B (ApoB)IBA 03/2006 - 05/2002
3	ApolipoproteinsIBA 03/2006 - 05/2002
2	AcidsIBA 12/2019 - 08/2003
2	Bile Acids and Salts (Bile Acids)IBA 02/2019 - 11/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2017 - 06/2009
2	Growth Hormone (Somatotropin)IBA 07/2017 - 05/2002
2	phytanoyl-coenzyme A (phytanoyl CoA)IBA 01/2017 - 02/2003
2	Mixed Function Oxygenases (Monooxygenases)IBA 01/2017 - 02/2003
2	mipomersenIBA 01/2016 - 09/2013
2	Carrier Proteins (Binding Protein)IBA 04/2012 - 05/2002
2	Creatine Kinase (Creatine Phosphokinase)IBA 03/2012 - 03/2005
2	Biomarkers (Surrogate Marker)IBA 07/2011 - 01/2006
2	Atorvastatin (Lipitor)FDA Link 07/2010 - 01/2002
2	Peptides (Polypeptides)IBA 11/2009 - 11/2004
2	HomocysteineIBA 06/2007 - 07/2003
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2006 - 07/2003
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 04/2004 - 07/2003
2	C-Reactive ProteinIBA 01/2004 - 07/2003
1	evinacumabIBA 12/2022
1	SphingolipidsIBA 01/2022
1	CeramidesIBA 01/2022
1	Ferritins (Ferritin)IBA 09/2021
1	Glucosylceramidase (Glucocerebrosidase)IBA 09/2021
1	Alkaline PhosphataseIBA 09/2021

Therapy/Procedure

33	Therapeutics 12/2022 - 05/2002
5	Secondary Prevention 12/2015 - 12/2006
3	Drug Therapy (Chemotherapy) 07/2017 - 02/2010
3	Highly Active Antiretroviral Therapy (HAART) 01/2012 - 11/2005
2	Radiotherapy 07/2017 - 07/2014